Open AccessLow molecular weight heparin in treating patients with lung cancer received chemotherapy
Author(s) -
Zili Liu,
Qian Wang,
Ming Wang,
Bin Wang,
Lingxia Huang
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.176174
Subject(s) - medicine , cochrane library , lung cancer , relative risk , meta analysis , inclusion and exclusion criteria , incidence (geometry) , confidence interval , low molecular weight heparin , randomized controlled trial , hazard ratio , chemotherapy , surgery , heparin , pathology , alternative medicine , physics , optics
To systematically review the efficacy and safety of low molecular weight heparin (LMWH) in treating patients with lung cancer received chemotherapy.